• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤分级变化对腹膜后肉瘤预后影响的分析

Analysis of the Effect of Tumor-Grade Change on the Prognosis of Retroperitoneal Sarcoma.

作者信息

Jo Sung Jun, Kim Kyeong Deok, Lim So Hee, Kim Jinseob, Kim Min Jung, Park Jae Berm, Lee Kyo Won

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Department of Surgery, Inha University Hospital, Inha University School of Medicine, Incheon 22332, Korea.

出版信息

Cancers (Basel). 2022 Jun 19;14(12):3020. doi: 10.3390/cancers14123020.

DOI:10.3390/cancers14123020
PMID:35740685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9221304/
Abstract

In retroperitoneal sarcoma (RPS), the change in the tumor grade from the primary tumor to the first local recurrence, and the effect of this change on prognosis, are unknown. The aim of this study is to analyze whether these changes affect the prognosis of RPS. Patients who underwent surgery for a first locally recurrent RPS at Samsung Medical Center from January 2001 to February 2020 were included. The pathologic features of primary and recurrent tumors were compared, and the outcomes were measured. A total of 49 patients were investigated. There were 25 patients with different grades of primary and recurrent tumors. The improving, stable, and worsening groups contained 16 (32.7%), 24 (49%), and 9 (18.3%) patients, respectively. There was no significant difference in the prognosis between the three groups. In the analyses of the factors that affect the OS, a high grade of the primary tumor ( = 0.023) and the size of the recurrent tumor ( = 0.032) were statistically significant in both univariate and multivariate analyses. In a factor analysis of the second LR, a high-grade recurrent tumor ( 0.032) was the only significant factor. There were tumor-grade changes between the primary tumor and recurrent tumor in RPS. However, the most important factor in prognosis is a high grade of the primary tumor.

摘要

在腹膜后肉瘤(RPS)中,肿瘤分级从原发肿瘤到首次局部复发的变化及其对预后的影响尚不清楚。本研究的目的是分析这些变化是否会影响RPS的预后。纳入了2001年1月至2020年2月在三星医疗中心接受首次局部复发性RPS手术的患者。比较原发肿瘤和复发性肿瘤的病理特征,并测量结果。共调查了49例患者。有25例患者的原发肿瘤和复发性肿瘤分级不同。改善组、稳定组和恶化组分别包含16例(32.7%)、24例(49%)和9例(18.3%)患者。三组之间的预后无显著差异。在影响总生存期的因素分析中,原发肿瘤的高分级(P = 0.023)和复发性肿瘤的大小(P = 0.032)在单因素和多因素分析中均具有统计学意义。在第二次局部复发的因素分析中,高分级复发性肿瘤(P = 0.032)是唯一的显著因素。RPS的原发肿瘤和复发性肿瘤之间存在肿瘤分级变化。然而,预后的最重要因素是原发肿瘤的高分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/7ae394d3e3d9/cancers-14-03020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/37d75512d3d1/cancers-14-03020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/a5b9879f210a/cancers-14-03020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/7ae394d3e3d9/cancers-14-03020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/37d75512d3d1/cancers-14-03020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/a5b9879f210a/cancers-14-03020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21d/9221304/7ae394d3e3d9/cancers-14-03020-g003.jpg

相似文献

1
Analysis of the Effect of Tumor-Grade Change on the Prognosis of Retroperitoneal Sarcoma.肿瘤分级变化对腹膜后肉瘤预后影响的分析
Cancers (Basel). 2022 Jun 19;14(12):3020. doi: 10.3390/cancers14123020.
2
Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.腹膜后肉瘤初次扩大切除术后复发后的结局:跨大西洋腹膜后肉瘤工作组的报告
Cancer. 2017 Jun 1;123(11):1971-1978. doi: 10.1002/cncr.30572. Epub 2017 Feb 2.
3
Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.复发性腹膜后肉瘤:手术治疗的临床结果和预后因素。
Eur J Surg Oncol. 2021 May;47(5):1201-1206. doi: 10.1016/j.ejso.2020.08.030. Epub 2020 Sep 9.
4
Patients with first recurrent retroperitoneal sarcoma that can be macroscopically completely resected can achieve comparable outcomes with that of primary patients after resection of tumor and adjacent organs.首次复发的腹膜后肉瘤患者若能在宏观上完全切除,在切除肿瘤及相邻器官后可获得与原发性患者相当的预后。
Front Surg. 2022 Sep 7;9:956384. doi: 10.3389/fsurg.2022.956384. eCollection 2022.
5
The Role of Preoperative F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma.术前氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在腹膜后肉瘤中的作用
Front Oncol. 2022 May 30;12:868823. doi: 10.3389/fonc.2022.868823. eCollection 2022.
6
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.预测接受局部复发性腹膜后肉瘤切除术患者的生存:TARPSWG 的研究和新的列线图。
Clin Cancer Res. 2019 Apr 15;25(8):2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. Epub 2019 Feb 5.
7
Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the .亚洲某单一三级中心首次复发后局部复发性腹膜后肉瘤的特征及预后,以及(此处原文不完整,无法准确翻译最后部分)的适用性
Front Oncol. 2021 Nov 25;11:730292. doi: 10.3389/fonc.2021.730292. eCollection 2021.
8
Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma.多次复发腹膜后软组织肉瘤切除术后的结果。
Eur J Surg Oncol. 2021 Aug;47(8):2189-2200. doi: 10.1016/j.ejso.2021.04.040. Epub 2021 May 4.
9
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.腹膜后肉瘤二次复发后的复发模式及生存概率:来自TARPSWG的一项研究
Cancer. 2020 Nov 15;126(22):4917-4925. doi: 10.1002/cncr.33139. Epub 2020 Aug 14.
10
Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.原发性腹膜后肉瘤(RPS)切除术后复发模式的变异性:来自多机构协作RPS工作组的1007例患者报告。
Ann Surg. 2016 May;263(5):1002-9. doi: 10.1097/SLA.0000000000001447.

引用本文的文献

1
Prognostic characteristics of a six-gene signature based on ssGSEA in sarcoma.基于单样本基因集富集分析(ssGSEA)的六基因特征在肉瘤中的预后特征
Aging (Albany NY). 2024 Jan 17;16(2):1536-1554. doi: 10.18632/aging.205443.
2
Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs.钬 - 166微球瘤内注射作为犬软组织肉瘤的新辅助治疗
Front Vet Sci. 2022 Nov 1;9:1015248. doi: 10.3389/fvets.2022.1015248. eCollection 2022.

本文引用的文献

1
Prognostic implications of histological organ involvement in retroperitoneal sarcoma.腹膜后肉瘤组织器官受累对预后的影响。
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab080.
2
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.多机构验证研究:腹膜后肉瘤预后列线图。
J Surg Oncol. 2021 Oct;124(5):829-837. doi: 10.1002/jso.26586. Epub 2021 Jul 13.
3
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
经 Transatlantic Australasian Retroperitoneal Sarcoma Working Group(TARPSWG)分析,腹膜后脂肪肉瘤首次复发时的分化变化及结果。
Ann Surg Oncol. 2021 Nov;28(12):7854-7863. doi: 10.1245/s10434-021-10024-y. Epub 2021 Apr 27.
4
Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.复发性腹膜后肉瘤:手术治疗的临床结果和预后因素。
Eur J Surg Oncol. 2021 May;47(5):1201-1206. doi: 10.1016/j.ejso.2020.08.030. Epub 2020 Sep 9.
5
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.术前放疗加手术与单纯手术治疗原发性腹膜后肉瘤患者(EORTC-62092:STRASS):一项多中心、开放标签、随机、III 期临床试验。
Lancet Oncol. 2020 Oct;21(10):1366-1377. doi: 10.1016/S1470-2045(20)30446-0. Epub 2020 Sep 14.
6
Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis.腹膜后肉瘤腹膜内侵犯:预后不良的危险因素。
Ann Surg Oncol. 2019 Oct;26(11):3535-3541. doi: 10.1245/s10434-019-07615-1. Epub 2019 Jul 16.
7
Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.腹膜后肉瘤切除术后的复发模式:来自美国肉瘤协作组的 8 家机构的研究。
J Surg Oncol. 2019 Sep;120(3):340-347. doi: 10.1002/jso.25606. Epub 2019 Jun 27.
8
Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.腹膜后肉瘤切除术后长期生存的结局及预测因素分析。
BMC Surg. 2019 Jun 10;19(1):61. doi: 10.1186/s12893-019-0521-9.
9
New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.腹膜后肉瘤的新研究策略。TARPSWG、STRASS 和 RESAR 的案例:通过合作取得进展。
Curr Opin Oncol. 2019 Jul;31(4):310-316. doi: 10.1097/CCO.0000000000000535.
10
Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.腹膜后肉瘤的新辅助和辅助治疗策略。
Eur J Surg Oncol. 2018 May;44(5):571-579. doi: 10.1016/j.ejso.2018.02.001. Epub 2018 Feb 9.